ATM and obesity due to melanocortin 4 receptor deficiency: Further research in dissecting ATM populations to identify a specific subset that supports the functions of thermogenic adipocytes may provide exciting perspectives in the field and establish an immune-targeting metabolic drug to improve systemic energy homeostasis and reverse the pathophysiology of obesity and other metabolic disorders.